“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis”, FE, vol. 25, no. 1, Dec. 2024, doi: 10.7175/fe.v25i1.1568.